U.S. Stock Market Anomaly | "Collaboration Clarification" Once Led to Sharp Decline, Mangoceuticals (MGRX.US) Stock Price Rides Roller Coaster

According to the Securities Times APP, on Friday, the remote medical platform Mangoceuticals (MGRX.US) experienced a pre-market drop of about 13%, but after the market opened, the stock recovered and slightly rose by 2.94%, closing at $1.225. Prior to this, the company denied any collaboration with Eli Lilly (LLY.US) and Novo Nordisk (NVO.US), contradicting a statement they had released just one day earlier.